Spravato (intranasal esketamine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Spravato (intranasal esketamine), covering 2025-04-27 to 2025-04-27. Get the full timeline:
Most recent: Clinical Trial Update: Crossover Study to Evaluate the Abuse Potential of Intranasal Esketamine Compared to Racemic Intravenous Ketamine in Nondependent, Recreational Drug Users [Phase 1]